$EXPI
EXP World Holdings, Inc.

2022 Q3 Form 10-Q Financial Statement

#000155837022015886 Filed on November 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q3
Revenue $1.239B
YoY Change 11.57%
Cost Of Revenue $1.146B
YoY Change 11.15%
Gross Profit $93.12M
YoY Change 17.07%
Gross Profit Margin 7.52%
Selling, General & Admin $93.10M
YoY Change 36.15%
% of Gross Profit 99.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.767M
YoY Change 63.34%
% of Gross Profit 2.97%
Operating Expenses $1.239B
YoY Change 12.7%
Operating Profit $26.00K
YoY Change -99.77%
Interest Expense -$329.0K
YoY Change -16550.0%
% of Operating Profit -1265.38%
Other Income/Expense, Net -$251.0K
YoY Change 5.91%
Pretax Income -$225.0K
YoY Change -102.06%
Income Tax -$4.627M
% Of Pretax Income
Net Earnings $4.402M
YoY Change -81.52%
Net Earnings / Revenue 0.36%
Basic Earnings Per Share $0.03
Diluted Earnings Per Share $0.03
COMMON SHARES
Basic Shares Outstanding 151.8M
Diluted Shares Outstanding 155.9M

Balance Sheet

Concept 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $134.5M
YoY Change 37.2%
Cash & Equivalents $134.5M
Short-Term Investments
Other Short-Term Assets $65.82M
YoY Change -15.87%
Inventory
Prepaid Expenses
Receivables $119.8M
Other Receivables $0.00
Total Short-Term Assets $320.2M
YoY Change 4.59%
LONG-TERM ASSETS
Property, Plant & Equipment $17.69M
YoY Change 34.15%
Goodwill $26.51M
YoY Change 104.82%
Intangibles $8.975M
YoY Change 16.66%
Long-Term Investments
YoY Change
Other Assets $65.29M
YoY Change 67.28%
Total Long-Term Assets $120.7M
YoY Change 59.86%
TOTAL ASSETS
Total Short-Term Assets $320.2M
Total Long-Term Assets $120.7M
Total Assets $440.9M
YoY Change 15.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.911M
YoY Change 15.85%
Accrued Expenses $117.6M
YoY Change 6.65%
Deferred Revenue $52.65M
YoY Change -24.14%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $180.4M
YoY Change -4.81%
LONG-TERM LIABILITIES
Long-Term Debt $2.714M
YoY Change 56.34%
Other Long-Term Liabilities $720.0K
YoY Change -15.19%
Total Long-Term Liabilities $2.714M
YoY Change 56.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $180.4M
Total Long-Term Liabilities $2.714M
Total Liabilities $183.8M
YoY Change -4.3%
SHAREHOLDERS EQUITY
Retained Earnings $34.62M
YoY Change 66.42%
Common Stock $567.6M
YoY Change 63.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $255.9M
YoY Change
Total Liabilities & Shareholders Equity $440.9M
YoY Change 15.52%

Cashflow Statement

Concept 2022 Q3
OPERATING ACTIVITIES
Net Income $4.402M
YoY Change -81.52%
Depreciation, Depletion And Amortization $2.767M
YoY Change 63.34%
Cash From Operating Activities $22.03M
YoY Change -28.92%
INVESTING ACTIVITIES
Capital Expenditures -$1.145M
YoY Change -67.75%
Acquisitions
YoY Change
Other Investing Activities -$9.668M
YoY Change 221.84%
Cash From Investing Activities -$10.81M
YoY Change 64.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -65.17M
YoY Change 12.34%
NET CHANGE
Cash From Operating Activities 22.03M
Cash From Investing Activities -10.81M
Cash From Financing Activities -65.17M
Net Change In Cash -53.95M
YoY Change 60.7%
FREE CASH FLOW
Cash From Operating Activities $22.03M
Capital Expenditures -$1.145M
Free Cash Flow $23.17M
YoY Change -32.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1099313000
us-gaap Operating Expenses
OperatingExpenses
3648649000
us-gaap Operating Income Loss
OperatingIncomeLoss
16117000
us-gaap Operating Income Loss
OperatingIncomeLoss
32609000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-394000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1213000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-251000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-237000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1607000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-164000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-225000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10930000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14510000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32445000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4627000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12884000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8115000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33258000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4402000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
23814000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4402000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
us-gaap Net Income Loss
NetIncomeLoss
22643000
us-gaap Net Income Loss
NetIncomeLoss
65717000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151826315
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146862978
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150622845
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001495932
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38493
dei Entity Registrant Name
EntityRegistrantName
EXP WORLD HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0681092
dei Entity Address Address Line1
EntityAddressAddressLine1
2219 Rimland Drive, Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Bellingham
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98226
dei City Area Code
CityAreaCode
360
dei Local Phone Number
LocalPhoneNumber
685-4206
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value per share
dei Trading Symbol
TradingSymbol
EXPI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
152702078
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134545000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108237000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
52652000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
67673000
CY2021Q4 us-gaap Liabilities
Liabilities
190293000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2714000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
720000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
765000
CY2022Q3 us-gaap Liabilities
Liabilities
183804000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2786000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2198000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119822000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
133489000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13167000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9916000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
320186000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
319315000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17689000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15902000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2217000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2482000
CY2022Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1614000
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2827000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8975000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7528000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
63672000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
52827000
CY2022Q3 us-gaap Goodwill
Goodwill
26514000
CY2021Q4 us-gaap Goodwill
Goodwill
12945000
CY2022Q3 us-gaap Assets
Assets
440867000
CY2021Q4 us-gaap Assets
Assets
413826000
CY2022Q3 expi Accounts Payable Prepaid Current
AccountsPayablePrepaidCurrent
9911000
CY2021Q4 expi Accounts Payable Prepaid Current
AccountsPayablePrepaidCurrent
7158000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
52652000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
67673000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
117605000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
111672000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
202000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
311000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
180370000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
186814000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2714000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168562464
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152702078
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148764592
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
567594000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
401479000
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15860386
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6751692
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-329000
CY2022Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
344844000
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
210009000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34616000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30510000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-1474000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
188000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
255894000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
222169000
CY2022Q3 us-gaap Minority Interest
MinorityInterest
1169000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1364000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257063000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
223533000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
440867000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
413826000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1238975000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1110480000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3664766000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2694200000
CY2022Q3 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1145853000
CY2021Q3 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1030937000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
3380930000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
2481254000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
89460000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64615000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
256173000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
171636000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3636000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3761000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11546000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8701000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1238949000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1099313000
us-gaap Operating Expenses
OperatingExpenses
3648649000
us-gaap Operating Expenses
OperatingExpenses
2661591000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
26000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
11167000
us-gaap Operating Income Loss
OperatingIncomeLoss
16117000
us-gaap Operating Income Loss
OperatingIncomeLoss
32609000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
78000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-239000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-394000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159000
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1213000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-251000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-237000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1607000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-164000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-225000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145610008
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155915307
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3881000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157345924
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10930000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14510000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4627000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12884000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8115000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33258000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4402000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
23814000
us-gaap Profit Loss
ProfitLoss
22625000
us-gaap Profit Loss
ProfitLoss
65703000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
us-gaap Net Income Loss
NetIncomeLoss
22643000
us-gaap Net Income Loss
NetIncomeLoss
65717000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151826315
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146862978
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145610008
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155915307
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157345924
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156434440
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157838134
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4402000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
23814000
us-gaap Profit Loss
ProfitLoss
22625000
us-gaap Profit Loss
ProfitLoss
65703000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4402000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
us-gaap Net Income Loss
NetIncomeLoss
22643000
us-gaap Net Income Loss
NetIncomeLoss
65717000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-521000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-131000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23690000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20981000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65657000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-521000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-131000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13663000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1662000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189568000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156434440
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157838134
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4402000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
23814000
us-gaap Profit Loss
ProfitLoss
22625000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4402000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
us-gaap Net Income Loss
NetIncomeLoss
22643000
us-gaap Net Income Loss
NetIncomeLoss
65717000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1662000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3881000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23690000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20981000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65657000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1662000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257063000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189568000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257063000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189568000
us-gaap Profit Loss
ProfitLoss
22625000
us-gaap Profit Loss
ProfitLoss
65703000
us-gaap Depreciation
Depreciation
5699000
us-gaap Depreciation
Depreciation
3572000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1455000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
939000
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
361000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
588000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
22000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1213000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
22828000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
18129000
us-gaap Share Based Compensation
ShareBasedCompensation
10872000
us-gaap Share Based Compensation
ShareBasedCompensation
9608000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
131230000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
101691000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
-10845000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
-36020000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13603000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52913000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3003000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1510000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-41625000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1952000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4597000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4770000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
-1446000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
187324000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
198413000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9222000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
139635000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-60000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
44561000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-150000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
111000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1500000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257063000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189568000
us-gaap Profit Loss
ProfitLoss
22625000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1455000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
939000
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
361000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
588000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
22000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1213000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
22828000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
18129000
us-gaap Share Based Compensation
ShareBasedCompensation
10872000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
101691000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
-10845000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13603000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52913000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3003000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1510000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
16135000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-41625000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1952000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4597000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4770000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
44561000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-150000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
111000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
-1446000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
187324000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
198413000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9222000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9159000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9668000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1500000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3004000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18890000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13663000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
139635000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
142103000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2221000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2695000
expi Payments To Proceeds From Noncontrolling Interests
PaymentsToProceedsFromNoncontrollingInterests
425000
us-gaap Payments Of Dividends
PaymentsOfDividends
18537000
us-gaap Payments Of Dividends
PaymentsOfDividends
5755000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-156376000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-145144000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-771000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3004000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18890000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
142103000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2221000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2695000
expi Payments To Proceeds From Noncontrolling Interests
PaymentsToProceedsFromNoncontrollingInterests
425000
expi Payments To Proceeds From Noncontrolling Interests
PaymentsToProceedsFromNoncontrollingInterests
-19000
us-gaap Payments Of Dividends
PaymentsOfDividends
18537000
us-gaap Payments Of Dividends
PaymentsOfDividends
5755000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-156376000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-145144000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-771000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-60000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11287000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39546000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187197000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167470000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
346000
us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
4800000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2381000
expi Fixed Asset Purchases In Accounts Payable
FixedAssetPurchasesInAccountsPayable
20000
expi Fixed Asset Purchases In Accounts Payable
FixedAssetPurchasesInAccountsPayable
150000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187197000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167470000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2933000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1060000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
346000
us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
4800000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2381000
expi Fixed Asset Purchases In Accounts Payable
FixedAssetPurchasesInAccountsPayable
20000
expi Fixed Asset Purchases In Accounts Payable
FixedAssetPurchasesInAccountsPayable
150000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimate</span>s</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;">historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">When necessary, the Company will reclassify certain amounts in prior-period financial statements to conform to the current period’s presentation. No reclassifications occurred during the current period.</p>
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9452025
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3478301
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimate</span>s</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;">historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">When necessary, the Company will reclassify certain amounts in prior-period financial statements to conform to the current period’s presentation. No reclassifications occurred during the current period.</p>
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98064000
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
69406000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167470000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108237000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
67673000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134545000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
52652000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187197000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9780000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
939000
CY2022Q3 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
343331
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100143000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
27781000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98064000
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
69406000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167470000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108237000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
67673000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
52652000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187197000
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
343331
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32174000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20850000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17363000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11711000
CY2022Q3 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
14811000
CY2021Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
9139000
CY2022Q3 expi Assets Under Development
AssetsUnderDevelopment
2878000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15902000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2129000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1376000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5699000
CY2022Q3 us-gaap Goodwill
Goodwill
26514000
CY2021Q4 us-gaap Goodwill
Goodwill
12945000
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15860386
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6012795
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32174000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20850000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17363000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11711000
CY2022Q3 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
14811000
CY2021Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
9139000
CY2022Q3 expi Assets Under Development
AssetsUnderDevelopment
2878000
CY2021Q4 expi Assets Under Development
AssetsUnderDevelopment
6763000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17689000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15902000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2129000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1376000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5699000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3572000
CY2022Q3 us-gaap Goodwill
Goodwill
26514000
CY2021Q4 us-gaap Goodwill
Goodwill
12945000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12679000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3704000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8975000
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11487691
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168562464
CY2021Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4725296
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12679000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3704000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8975000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9780000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2252000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7528000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
638000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
318000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1455000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
939000
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163286569
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151146986
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146677786
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
681139
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
337234
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2044193
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2682142
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168562464
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153549867
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153549867
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6751692
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2534494
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163286569
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151146986
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146677786
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
681139
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
337234
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2044193
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2682142
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168562464
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153549867
CY2021 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
4341000
expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
3466000
expi Stock Grants Reclassified From Liability To Equity
StockGrantsReclassifiedFromLiabilityToEquity
2430000
CY2022Q3 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
5377000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.50
CY2018Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000
CY2022Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4716026
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
845162
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
75680
CY2021Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1287499
CY2021 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
4341000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.50
CY2018Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11487691
CY2021Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4725296
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2534494
CY2022Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4716026
CY2021Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1287499
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9452025
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3478301
CY2022Q3 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
343331
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
343331
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15860386
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6012795
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15860386
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6012795
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.025
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33260000
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6012795
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
us-gaap Net Income Loss
NetIncomeLoss
22643000
us-gaap Net Income Loss
NetIncomeLoss
65717000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151826315
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146862978
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150622845
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145610008
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4088992
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12228126
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155915307
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157838134
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1315861
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
132704
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
845162
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
75680
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8120000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33260000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.562
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.025
CY2022Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
10000000.0
CY2022Q2 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
25000000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4402000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
23821000
us-gaap Net Income Loss
NetIncomeLoss
22643000
us-gaap Net Income Loss
NetIncomeLoss
65717000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151826315
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146862978
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150622845
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145610008
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4088992
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10482946
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5811595
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12228126
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155915307
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157345924
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156434440
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157838134
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1315861
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
132704
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8120000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.562
CY2022Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
10000000.0
CY2022Q2 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
25000000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1

Files In Submission

Name View Source Status
expi-20220930_def.xml Edgar Link unprocessable
expi-20220930_lab.xml Edgar Link unprocessable
expi-20220930_pre.xml Edgar Link unprocessable
expi-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001558370-22-015886-index-headers.html Edgar Link pending
0001558370-22-015886-index.html Edgar Link pending
0001558370-22-015886.txt Edgar Link pending
0001558370-22-015886-xbrl.zip Edgar Link pending
expi-20220930.xsd Edgar Link pending
expi-20220930x10q.htm Edgar Link pending
expi-20220930x10q001.jpg Edgar Link pending
expi-20220930xex31d1.htm Edgar Link pending
expi-20220930xex31d2.htm Edgar Link pending
expi-20220930xex32d1.htm Edgar Link pending
expi-20220930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
expi-20220930x10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending